| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |